29
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Lansoprazole versus Omeprazole in Active Duodenal Ulcer a Double-Blind, Randomized, Comparative Study

, , , , &
Pages 210-215 | Received 18 Feb 1994, Accepted 20 Jun 1994, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

David A Gremse. (2001) Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses. Expert Opinion on Pharmacotherapy 2:10, pages 1663-1670.
Read now
M. Thoring, H. Hedenström, L. S. Eriksson. (1999) Rapid Effect of Lansoprazole on Intragastric pH: a Crossover Comparison with Omeprazole. Scandinavian Journal of Gastroenterology 34:4, pages 341-345.
Read now

Articles from other publishers (16)

Xiangbo Meng, Xiuying Zhu, Baixue Li, Jibin Liu, Jiawei Zhao, Hua Wang, Quansheng Feng & Yue Su. (2023) Efficacy and safety of proton pump inhibitors and H2 receptor antagonists in the initial non‑eradication treatment of duodenal ulcer: A network meta‑analysis. Experimental and Therapeutic Medicine 25:6.
Crossref
Márcia Fernanda Correia Jardim Paz, Marcus Vinícius Oliveira Barros de Alencar, Rodrigo Maciel Paulino de Lima, André Luiz Pinho Sobral, Glauto Tuquarre Melo do Nascimento, Cristiane Amaral dos Reis, Maria do Perpetuo Socorro de Sousa Coêlho, Maria Luísa Lima Barreto do Nascimento, Antonio Luiz Gomes Júnior, Kátia da Conceição Machado, Ag-Anne Pereira Melo de Menezes, Rosália Maria Torres de Lima, José Williams Gomes de Oliveira Filho, Ana Carolina Soares Dias, Antonielly Campinho dos Reis, Ana Maria Oliveira Ferreira da Mata, Sônia Alves Machado, Carlos Dimas de Carvalho Sousa, Felipe Cavalcanti Carneiro da Silva, Muhammad Torequl Islam, João Marcelo de Castro e Sousa & Ana Amélia de Carvalho Melo Cavalcante. (2020) Pharmacological Effects and Toxicogenetic Impacts of Omeprazole: Genomic Instability and Cancer. Oxidative Medicine and Cellular Longevity 2020, pages 1-21.
Crossref
Jiaxing Zhang, Long Ge, Matt Hill, Yi Liang, Juan Xie, Dejun Cui, Xiaosi Li, Wenyi Zheng & Rui He. (2019) Standard-Dose Proton Pump Inhibitors in the Initial Non-eradication Treatment of Duodenal Ulcer: Systematic Review, Network Meta-Analysis, and Cost-Effectiveness Analysis. Frontiers in Pharmacology 9.
Crossref
Naoki Chiba. 2010. Evidence‐Based Gastroenterology and Hepatology. Evidence‐Based Gastroenterology and Hepatology 102 138 .
Naoki Chiba. 2004. Evidence‐based Gastroenterology and Hepatology. Evidence‐based Gastroenterology and Hepatology 83 116 .
David L. Whaley, Curtis M. Warren & David L. Thomas. (2004) Drug Switching: The Bottom Line Isn’t Always What It Seems. Journal of Correctional Health Care 10:2, pages 227-237.
Crossref
N. Vakil & M. B. Fennerty. (2003) Direct comparative trials of the efficacy of proton pump inhibitors in the management of gastro-oesophageal reflux disease and peptic ulcer disease. Alimentary Pharmacology & Therapeutics 18:6, pages 559-568.
Crossref
R. M. Klok, M. J. Postma, B. A. Van Hout & J. R. B. J. Brouwers. (2003) Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term use. Alimentary Pharmacology & Therapeutics 17:10, pages 1237-1245.
Crossref
Donald J. AbrahamSonia Roberts & Iain M. McDonald. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 75 117 .
Michelle M. Sodorff, Kimberly A. Galt, Michael A. Galt, Paul D. Turner & Jason E. Lambrecht. (2012) Patient Perceptions of a Proton Pump Inhibitor Therapeutic Interchange Program Across the Continuum of Care. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 22:4, pages 500-512.
Crossref
Alan B. R. Thomson. (2000) Are the orally administered proton pump inhibitors equivalent? A comparison of lansoprazole, omeprazole, pantoprazole, and rabeprazole. Current Gastroenterology Reports 2:6, pages 482-493.
Crossref
C. A. M. Stedman & M. L. Barclay. (2001) Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Alimentary Pharmacology & Therapeutics 14:8, pages 963-978.
Crossref
Giorgio Dobrilla, Lucia Piazzi & Roberto Fiocca. (1999) Lansoprazole versus omeprazole for duodenal ulcer healing and prevention of relapse: A randomized, multicenter, double-masked trial. Clinical Therapeutics 21:8, pages 1321-1332.
Crossref
Ch. Florent. (1999) Mise au point lansoprazole: pharmacocinétique, pharmacodynamique et activité thérapeutiqueLansoprazole: pharmacokinetic, pharmacodynamic and clinical efficacy: a review. Acta Endoscopica 29:2, pages 157-168.
Crossref
Pohle, Stoll, Kirchner, Heep, Lehn, Bock & Domschke. (2002) Eradication of Helicobacter pylori with lansoprazole, roxithromycin and metronidazole—an open pilot study . Alimentary Pharmacology & Therapeutics 12:12, pages 1273-1278.
Crossref
Geus, Mulder, Nicolai, D. M. Van Den Boomgaard & Lamers. (2001) Acid‐inhibitory effects of omeprazole and lansoprazole in Helicobacter pylori ‐negative healthy subjects . Alimentary Pharmacology & Therapeutics 12:4, pages 329-335.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.